- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04159038
Integrating WIC With Early Childhood Systems of Developmental Care (CDC-WIC)
Study Overview
Status
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Oregon
-
Bend, Oregon, United States, 97701
- Deschutes County WIC
-
Grants Pass, Oregon, United States, 97526
- Josephine County WIC
-
Hillsboro, Oregon, United States, 97124
- Washington County WIC
-
Madras, Oregon, United States, 97741
- Jefferson County WIC
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- The primary subject population of interest are Women, Infants, & Children families who in the course of a WIC visit identify a potential developmental concern and agree to a direct referral from WIC to Early Intervention to further assess that concern. To be eligible for the study, the parent/guardian must speak English or Spanish. The child with the identified concern must be under 54 months of age as the investigators will need to follow the child for 6 months to determine initial outcomes and children are no longer eligible for WIC after their 5th birthday.
WIC staff at the 4 intervention agencies, EI staff in the 4 communities in which the 4 intervention WIC Local Agencies are located, and primary care providers (PCPs) who have had a patient referred to EI directly from WIC will all be invited to participate in a telephone interview to give their perspective on the process. The only staff inclusion requirement is that these staff are currently working in their professional role in the county studied.
Exclusion Criteria:
- Family speaks language that isn't English or Spanish. Child is older than 54 months.
Staff does not work in their professional role in the county studied.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Allocation: RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Immediate Intervention Group
Parents in the immediate intervention arm sign a study consent that is integrated into the WIC Referral Form.
They also complete a brief demographic survey.
No consent is necessary in the delayed intervention arm as only aggregate information will be reported to the study team by EI/ECSE.
EI/ECSE referrals are tracked from clinics in both arms for 6 months in ecWeb.
At the end of the data collection period, the study team will meet to refine the intervention based on the experience with the immediate intervention group.
Qualitative Interviews will take place with WIC staff, parents who indicate interest, EI/ECSE staff, and primary care providers during and after the post-intervention data collection period.
|
The immediate intervention group will receive training on how to identify children at risk for developmental disabilities and how to refer to Early Intervention/Early Childhood Special Education.
|
OTHER: Delayed Intervention Group
6 months after the immediate intervention group receives their training, the delayed intervention group will receive the training.
Prior to implementation of the training in the delayed intervention group, the study team will meet with the Stakeholder Advisory Board.
It will review interim results and consider the efficacy of the intervention as a whole.
Based on actual use patterns and stakeholder feedback, the investigators will make improvements to the intervention prior to implementing it in the delayed intervention group.
|
The control group will continue usual WIC care.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
% of Women, Infants, & Children (WIC) participant visits with Early Intervention/Early Childhood Special Education (EI/ECSE) referral.
Time Frame: Start of intervention for 6 months
|
in immediate versus delayed intervention arms, to understand if the intervention boosted EI/ECSE referral rates.
|
Start of intervention for 6 months
|
% EI/ECSE referrals evaluated by EI/ECSE
Time Frame: Start of intervention for 6 months
|
by 6 months after referral, in both arms, to see if increased referral actually results in increased EI/ECSE evaluation.
|
Start of intervention for 6 months
|
Time from referral to evaluation
Time Frame: Start of intervention for 6 months
|
in both arms, to see if the intervention accelerated EI/ECSE evaluation.
|
Start of intervention for 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
% of those found eligible on EI/ECSE treatment, 6-months post referral
Time Frame: Start of intervention for 6 months
|
to see if the intervention increased the number of children receiving treatment services in EI/ECSE.
|
Start of intervention for 6 months
|
% of public-health identified children referred to EI/ECSE by WIC
Time Frame: Start of intervention for 6 months
|
to see if WIC can identify and refer children who are high-risk but not otherwise accessing developmental care.
|
Start of intervention for 6 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Katharine Zuckerman, M.D., M.P.H., Oregon Health and Science University
Publications and helpful links
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY00019833
- 19-3773 PO# 2000043062 (OTHER_GRANT: Centers for Disease Control and Prevention)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Developmental Disability
-
University of Alabama at BirminghamRecruitingDevelopmental Disability | Disability Physical | Physical InactivityUnited States
-
Vestvagoy MunicipalityUniversity of Oslo; University of TromsoActive, not recruitingDisability, Developmental | Disabilities, IntellectualNorway
-
University of Wisconsin, MadisonVirginia Commonwealth UniversityRecruitingDevelopmental DisabilityUnited States
-
Chang Gung UniversityCompletedDevelopmental DisabilityTaiwan
-
Kaohsiung Medical University Chung-Ho Memorial...CompletedDevelopmental DisabilityTaiwan
-
The Hong Kong Polytechnic UniversityUniversity of Otago; Food and Health Bureau, Hong Kong; National Cheng Kung UniversityRecruitingDevelopmental DisabilityHong Kong
-
Skidmore CollegeTerminated
-
ElTyeb, Sara Amir Hassan, M.D.Sudan Medical Specialization Board (SMSB); Elfatih Malik, MDCompletedDevelopmental Disability
-
University of Missouri-ColumbiaRecruitingPediatric Disorder | Disability, DevelopmentalUnited States
-
University of Illinois at ChicagoUniversity of Colorado, Denver; Rocky Mountain Human ServicesCompletedDevelopmental Disability | Development Delay
Clinical Trials on Intervention Group
-
Muğla Sıtkı Koçman UniversityNot yet recruiting
-
University of LiegeCentre Hospitalier Universitaire de Liege; Bial Foundation; FNRS (Télévie); Fondation...RecruitingPain | Cancer | Fatigue | Cognitive Impairment | Sleep Disturbance | Distress, EmotionalBelgium
-
Hospital de Clinicas de Porto AlegreUnknown
-
University of California, San FranciscoNational Cancer Institute (NCI); Cancer Prevention Institute of CaliforniaCompletedHereditary Breast and Ovarian Cancer Syndrome
-
University of Sao PauloCompletedAnxiety | Self Esteem
-
Haute Ecole de Santé VaudCompletedArthroplasty, Replacement, Knee | Arthroplasty, Replacement, HipSwitzerland
-
Azienda Ospedaliero-Universitaria CareggiRecruiting
-
University of North Carolina, Chapel HillNational Heart, Lung, and Blood Institute (NHLBI)CompletedHeart Diseases | Cardiovascular Diseases
-
University of OxfordOxford Brookes UniversityRecruitingOverweight/Obesity, AdolescentUnited Kingdom
-
Beijing Tsinghua Chang Gung HospitalRecruitingLifestyle Intervention | Non Communicable DiseasesChina